Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide plus CHOP-like regimen in newly diagnosed aggressive T-cell lymphoma
ChiCTR-IPR-16008640Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of thalidomide in T-cell lymphoma (2 arms), sponsored by Union Hospital. Primary endpoints: Progression-free survival, Total efficiency and 1 more. Started Jul 2016; status: recruiting.
02
Drugs
thalidomide
03
Conditions
T-cell lymphoma
Beyond the preview
Go deeper on ChiCTR-IPR-16008640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008640.